$BIOX

Bioceres Crop Solutions Corp. (BIOX): Financial results for Q4 2026

Bioceres Crop Solutions Corp. (BIOX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results Total revenues were $55.9 million in 4Q26 and $238.3 million in FY26 ROSARIO, Argentina – September 14, 2026 – Bioceres Crop Solutions Cor

Original reporting
Published Sep 15, 2026, 11:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BIOX
Bullish
high confidence
Mentioned
$BIOX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$BIOXBullishMed
01

Why it matters

Earnings show revenue stability but a significant decline YoY, with cost cuts narrowing losses and delivering positive Adjusted EBITDA.

02

Market read

First‑report earnings for a micro‑cap agritech stock; may trigger short‑term trading activity.

03

What to watch

Foreclosure of Pro Farm Group could pose future liquidity risk.

Relevance 7/10Novelty 8/10Timing: after-hours filing Sep 15

Background

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) filed a Form 6‑K reporting its Q4 and full‑year 2026 results.

Company-level read

Ticker impact

$BIOXBullishHigh confidence
Context

Bioceres released its Q4 2026 earnings with revenue of $55.9M and a narrowed net loss, marking the first public disclosure of these figures.

Expected impact

Potential modest rally as investors reassess loss trajectory.

Evidence & confidence

Improved loss and EBITDA indicate operational progress, likely prompting buying interest.

Market effects

Signals challenges in seed business for agri‑tech sector.

May affect Argentine agribusiness sentiment.

Limited to niche crop‑solution investors.

Counterpoint

Losses remain sizable; price may still be pressured despite EBITDA turn.

Key entities

  • Bioceres Crop Solutions Corp.

    Agricultural biotech firm reporting earnings.

  • Federico Trucco

    CEO providing commentary on results.

Related articles

$BIOXMed

Bioceres (BIOX) Q4 2026 Earnings Call Transcript

Bioceres (BIOX) reported a challenging fiscal year 2026 with an 18% revenue decline to $238M, driven by seed business reconfiguration and lower crop protection performance. Quarterly revenue was $55.9M, with crop nutrition revenue growing 36%. Adjusted EBITDA improved to $600K from a $9.6M loss, aided by a 19% reduction in SG&A expenses. The company faces litigation and debt restructuring challenges, with total financial debt at $225.9M. Management targets a 40% gross margin for fiscal 2027 and

Med

5-star analyst resets SanDisk stock price target by $175

Mizuho analyst Vijay Rakesh raised SanDisk's (SNDK) price target to $2,050, citing strong demand for AI storage. SanDisk's Q4 2026 revenue was $8.97B, up 51% sequentially. FY 2026 revenue reached $20.25B, up 175% YoY. Analysts highlight durable AI-driven demand for NAND storage, with SanDisk's tech improving cost efficiency.

$005930.KSHighAI 9/10

Samsung's Q3 Profit Guidance Tops Analyst Estimates As AI Demand Outstrips Memory Supply

Samsung Electronics (SSNLF) guided Q3 profit and sales growth, exceeding analyst estimates, driven by AI demand for memory chips. Sales are expected to reach KRW 195 trillion ($145.76 billion), with operating profit at KRW 107.40 trillion ($80.30 billion). Samsung, SK Hynix (SKHY), and Micron (MU) are benefiting from tight supply. Samsung shares in Seoul fell 0.84%.

$STZHighAI 9/10

STZ Stock Looks To Snap 7 Weeks Of Losses: Why Goldman Sachs Is Bullish Despite Slashing Price Target

Goldman Sachs cut Constellation Brands' (STZ) price target to $155 from $180 but maintained a 'Buy' rating, citing potential 31% upside. The company reported Q1 EPS of $3.74, beating estimates, and expects FY27 results to approach the upper end of guidance. CEO Nicholas Fink highlighted plans for renewed beer growth through marketing and new products. STZ stock has gained nearly 5% this week.

$005930.KSMedAI 8/10

Samsung Q3 2026 Guidance: 195T Won Sales, 107T Won Profit

Samsung Electronics projected Q3 2026 sales of 195 trillion won and operating profit of 107.40 trillion won, driven by strong demand in semiconductors and consumer electronics. The guidance reflects growth in memory chips and Galaxy smartphones, with Samsung navigating market challenges effectively. The company's operational improvements also contributed to the outlook.